Catalyst Pharmaceutical Inc (NASDAQ: CPRX) stock closed at $22.80 on 1/8/25 after a major increase of 16.7%. Moreover, this advance was accompanied by exceptionally high trading volume at 299% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 8.2% during the last week.
Current PriceTarget Research Rating
Catalyst Pharmaceutical has a current Value Trend Rating of A (Highest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Catalyst Pharmaceutical has a good Power Rating of 78 and a very high Appreciation Score of 89, resulting in the Highest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment